Halozyme Therapeutics Inc (HALO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Halozyme Therapeutics Inc   (NASDAQ: HALO)
 

Halozyme Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Halozyme Therapeutics Inc inventory turnover ratio, the Halozyme Therapeutics Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.79 in the second quarter 2026, HALO's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Halozyme Therapeutics Inc in Jun 30 2026 quarter, has decreased to 204 days, compare to 245 days, in the Mar 31 2026 quarter.

Within Healthcare sector 225 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1040 in the first quarter 2026, to 1442.

HALO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Halozyme Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HALO Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -24.45 % -5.7 % 24.4 % 41.38 % 13.93 %
Y / Y Cost of Sales Growth 70.78 % 63.7 % 87.3 % 11.77 % 17.05 %
Inventory Turnover Ratio (TTM) 1.79 1.49 1.29 1.14 1.2
HALO's Total Ranking # 1442 # 1040 # 1129 # 656 #
Average inventory processing period 204 246 283 320 304
Seq. Inventory Growth -11.79 % -11.9 % -5.02 % 2.36 % 10.09 %
Seq. Cost of Sales Growth -0.08 % 0.59 % 42.59 % 19.16 % -4.22 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 18
Healthcare Sector # 226
Overall Market # 1442

Inventory Turnover Ratio Statistics
High Average Low
3.64 1.73 0.23
(Jun 30 2015)   (Jun 30 2012)



HALO Company Profile >> Back to HALO Efficiency Comparisons >> Compare HALO Inventory Turnover Ratio to its Competitors

Financial Statements
Halozyme Therapeutics Inc 's Inventories $ 137 Millions Visit HALO's Balance sheet
Halozyme Therapeutics Inc 's Cost of Revenues TTM $ 292 Millions Visit HALO's Income Statement
What are HALO's Sales? Visit HALO's Sales by Segment

Other Inventory Turnover Ratios
Halozyme Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HALO's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HALO's Competitors
Inventory Turnover Ratio for HALO's Suppliers
Inventory Turnover Ratio for HALO's Customers

You may also want to know
HALO's Sales Growth Rates HALO's Pe Price to earnings ratio HALO's Receivables Turnover Ratio HALO's Stock Quote
HALO's Net Income Growth Rates HALO's Ps Price to Sales ratio HALO's Sales per Employee HALO's Asset Turnover Ratio
HALO's Net Margin HALO's Pb Price to Book ratio HALO's Financial Strength Ratios HALO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions

Date modified: 2026-09-08T01:18:12+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.